Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

PHASE3CompletedINTERVENTIONAL

Enrollment

684

Participants

Timeline

Start Date

October 31, 1998

Primary Completion Date

June 30, 2001

Conditions

Asthma

Interventions

DRUG

Respimat® Budesonide low dose

DRUG

Respimat® Budesonide high dose

DRUG

Turbohaler® Budesonide

DRUG

Placebo